| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $459.5M | — | -3.8% |
| Cost of Revenue | $380.3M | — | +0.2% |
| Gross Profit | $79.2M | — | -19.3% |
| R&D Expense | $7.3M | — | +10.6% |
| SG&A Expense | $59.1M | — | +1.2% |
| Operating Income | $11.4M | — | -63.5% |
| Pre-tax Income | -$3.3M | — | -118.9% |
| Income Tax | $6.7M | — | -24.7% |
| Net Income | -$9.9M | — | -208.8% |
| EPS (Basic) | -$0.18 | — | -212.5% |
| EPS (Diluted) | -$0.18 | — | -212.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $50.5M | -16.8% | +34.7% |
| Accounts Receivable | $270.5M | +26.6% | -1.3% |
| Inventory | $251.0M | -9.5% | -15.5% |
| Current Assets | $661.5M | +2.7% | -3.9% |
| Total Assets | $1.93B | +1.2% | -1.9% |
| Current Liabilities | $659.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.4M | — | -3200.0% |
| Investing Cash Flow | -$36.1M | — | -23.6% |
| Financing Cash Flow | $39.6M | — | +81.7% |
| +9.6% |
| Long-term Debt | $662.5M | -1.8% | +0.5% |
| Stockholders' Equity | $379.5M | -1.3% | -18.6% |